Old Web
English
Sign In
Acemap
>
authorDetail
>
Emanuel P. DeNoia
Emanuel P. DeNoia
Medicine
Pharmacology
Pharmacokinetics
Raltegravir
In vivo
4
Papers
104
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intraosseous vascular access using the EZ-IO can be safely maintained in the adult proximal humerus and proximal tibia for up to 48 h: Report of a clinical study:
2021
Journal of Vascular Access
Thomas Philbeck
Tatiana Puga
Diana Montez
Chris Davlantes
Emanuel P. DeNoia
Larry J. Miller
Show All
Source
Cite
Save
Citations (0)
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 (rHuPH20) Administered Intravenously in Healthy Volunteers
2020
Current Therapeutic Research-clinical and Experimental
Marie A. Printz
Samuel S. Dychter
Emanuel P. DeNoia
Rena Harrigan
Barry J. Sugarman
Monica L. Zepeda
Jennifer Souratha
David W. Kang
Daniel C. Maneval
Show All
Source
Cite
Save
Citations (3)
Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation
2011
The Journal of Clinical Pharmacology
Diana M. Brainard
Kelem Kassahun
Larissa Wenning
Amelia S. Petry
Chengcheng Liu
Jared Lunceford
Niresh Hariparsad
Roy Eisenhandler
Alisha Norcross
Emanuel P. DeNoia
Julie A. Stone
John A. Wagner
Marian Iwamoto
Show All
Source
Cite
Save
Citations (25)
Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation
2008
The Journal of Clinical Pharmacology
Marian Iwamoto
Kelem Kassahun
Matthew D. Troyer
William D. Hanley
Ping Lu
Alisha Rhoton
Amelia S. Petry
Kalyan Ghosh
Eric Mangin
Emanuel P. DeNoia
Larissa Wenning
Julie A. Stone
Keith M. Gottesdiener
John A. Wagner
Show All
Source
Cite
Save
Citations (76)
1